Investec Investec India

Vaccine Supply Modelling for India: Supplies set to improve

Loading player...
As India grapples with the devastating and deadly Covid-19 second wave, the vaccination drive has come as a glimmer of hope. But there are many questions surrounding this biggest drive in the world primarily around capacity and pricing.
To answer these questions Swapna Bhandarkar spoke with Anshuman Gupta, India's leading pharma analyst. Anshuman recently released a research report titled - India Pharmaceuticals: Vaccine Supply Modelling for India: Supplies set to improve. The report is supported by a detailed Working Excel Model that takes into account various factors that will aid the vaccination drive in India.
29 Apr 2021 English South Africa Business · Investing

Other recent episodes

Rising Stress in MFI - A Perspective from Credit Rating Agency

As of March 2024, the Gross loan portfolio of Micro Finance industry has grown to Rs 4.42 lakh crore, up 26.8% over the previous year. Though active loans have grown 14% YoY, the Average ticket size has also increased by 12% YoY. While the industry witnessed best of asset quality…
31 Oct 2024 52 min

Investec India - UK Economic Crisis and its impact on India with Mr Philip Shaw,

Last week saw continued turmoil in financial markets, culminating in the Bank of England acting with an (up to) £65bn emergency intervention, in an attempt to calm domestic markets and restore financial stability. This was in response to the reaction in longer-dated gilt markets – particularly at the 30-year maturity…
6 Oct 2022 52 min
All episodes